Journal article 1258 views 2022 downloads
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain,
Andreas L. Birkenfeld,
Morten Donsmark,
Kathleen Dungan,
Freddy G. Eliaschewitz,
Denise R. Franco,
Ole K. Jeppesen,
Ildiko Lingvay,
Ofri Mosenzon,
Sue D. Pedersen,
Cees J. Tack,
Mette Thomsen,
Tina Vilsbøll,
Mark L. Warren,
Steve Bain
New England Journal of Medicine, Volume: 381, Issue: 9, Pages: 841 - 851
Swansea University Author: Steve Bain
-
PDF | Version of Record
Copyright © 2019 Massachusetts Medical Society. Reprinted with permission
Download (239.22KB)
DOI (Published version): 10.1056/nejmoa1901118
Abstract
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Published in: | New England Journal of Medicine |
---|---|
ISSN: | 0028-4793 1533-4406 |
Published: |
Massachusetts Medical Society
2019
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa51010 |
first_indexed |
2019-07-04T14:55:48Z |
---|---|
last_indexed |
2023-01-11T14:27:39Z |
id |
cronfa51010 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-12-02T19:01:17.5690089</datestamp><bib-version>v2</bib-version><id>51010</id><entry>2019-07-04</entry><title>Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-07-04</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>New England Journal of Medicine</journal><volume>381</volume><journalNumber>9</journalNumber><paginationStart>841</paginationStart><paginationEnd>851</paginationEnd><publisher>Massachusetts Medical Society</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0028-4793</issnPrint><issnElectronic>1533-4406</issnElectronic><keywords/><publishedDay>29</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-08-29</publishedDate><doi>10.1056/nejmoa1901118</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T19:01:17.5690089</lastEdited><Created>2019-07-04T11:29:42.7448228</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mansoor</firstname><surname>Husain</surname><order>1</order></author><author><firstname>Andreas L.</firstname><surname>Birkenfeld</surname><order>2</order></author><author><firstname>Morten</firstname><surname>Donsmark</surname><order>3</order></author><author><firstname>Kathleen</firstname><surname>Dungan</surname><order>4</order></author><author><firstname>Freddy G.</firstname><surname>Eliaschewitz</surname><order>5</order></author><author><firstname>Denise R.</firstname><surname>Franco</surname><order>6</order></author><author><firstname>Ole K.</firstname><surname>Jeppesen</surname><order>7</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>8</order></author><author><firstname>Ofri</firstname><surname>Mosenzon</surname><order>9</order></author><author><firstname>Sue D.</firstname><surname>Pedersen</surname><order>10</order></author><author><firstname>Cees J.</firstname><surname>Tack</surname><order>11</order></author><author><firstname>Mette</firstname><surname>Thomsen</surname><order>12</order></author><author><firstname>Tina</firstname><surname>Vilsbøll</surname><order>13</order></author><author><firstname>Mark L.</firstname><surname>Warren</surname><order>14</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>15</order></author></authors><documents><document><filename>51010__16510__4cd4201df80e4682845b84b0ebe203f0.pdf</filename><originalFilename>51010.pdf</originalFilename><uploaded>2020-02-03T12:24:43.3704210</uploaded><type>Output</type><contentLength>244958</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-12-11T00:00:00.0000000</embargoDate><documentNotes>Copyright © 2019 Massachusetts Medical Society. Reprinted with permission</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-12-02T19:01:17.5690089 v2 51010 2019-07-04 Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-07-04 MEDS Journal Article New England Journal of Medicine 381 9 841 851 Massachusetts Medical Society 0028-4793 1533-4406 29 8 2019 2019-08-29 10.1056/nejmoa1901118 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2022-12-02T19:01:17.5690089 2019-07-04T11:29:42.7448228 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mansoor Husain 1 Andreas L. Birkenfeld 2 Morten Donsmark 3 Kathleen Dungan 4 Freddy G. Eliaschewitz 5 Denise R. Franco 6 Ole K. Jeppesen 7 Ildiko Lingvay 8 Ofri Mosenzon 9 Sue D. Pedersen 10 Cees J. Tack 11 Mette Thomsen 12 Tina Vilsbøll 13 Mark L. Warren 14 Steve Bain 0000-0001-8519-4964 15 51010__16510__4cd4201df80e4682845b84b0ebe203f0.pdf 51010.pdf 2020-02-03T12:24:43.3704210 Output 244958 application/pdf Version of Record true 2019-12-11T00:00:00.0000000 Copyright © 2019 Massachusetts Medical Society. Reprinted with permission true eng |
title |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
spellingShingle |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Steve Bain |
title_short |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
title_full |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
title_fullStr |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
title_full_unstemmed |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
title_sort |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
Mansoor Husain Andreas L. Birkenfeld Morten Donsmark Kathleen Dungan Freddy G. Eliaschewitz Denise R. Franco Ole K. Jeppesen Ildiko Lingvay Ofri Mosenzon Sue D. Pedersen Cees J. Tack Mette Thomsen Tina Vilsbøll Mark L. Warren Steve Bain |
format |
Journal article |
container_title |
New England Journal of Medicine |
container_volume |
381 |
container_issue |
9 |
container_start_page |
841 |
publishDate |
2019 |
institution |
Swansea University |
issn |
0028-4793 1533-4406 |
doi_str_mv |
10.1056/nejmoa1901118 |
publisher |
Massachusetts Medical Society |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2019-08-29T07:42:52Z |
_version_ |
1821299937364672512 |
score |
11.047306 |